中国医疗保健 - 中美药物对外授权动态 - 影响与情景分析-China Healthcare_ US-China drug out-licensing newsflow_ Implications and scenario analysis
2025-09-11 12:11
更多资料加入知识星球：水木调研纪要 关注公众号：水木纪要 Ziyi Chen +852-2978-0526 | ziyi.chen@gs.com Goldman Sachs (Asia) L.L.C. 11 September 2025 | 8:32AM HKT Linhai Zhao, Ph.D. +852-3966-4059 | linhai.zhao@gs.com Goldman Sachs (Asia) L.L.C. On September 10th, the New York Times reported that the Trump administration has been discussing restrictions on medicines from China, with a draft executive order (EO) that aims to limit the China-invented drug pipeline, through several proposed policies: 1) stricter scrutiny on US pharma licens ...